For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230703:nRSC6343Ea&default-theme=true
RNS Number : 6343E Assura PLC 03 July 2023
3 July 2023
Assura plc
Change of Registered Office Address
Assura plc ("Assura" or "the Company"), the UK's leading primary care property
investor and developer, announces that the Company's registered office address
has changed to 3 Barrington Road, Altrincham, WA14 1GY with immediate effect.
In line with Assura's net zero carbon ambition, plans are in place to renovate
and refurbish the building to minimise energy consumption, with works
including window replacement, improvements to thermal insulation of the
building fabric, enhanced building controls and extensive use of recycled
materials where possible.
- ENDS -
For more information, please contact:
Assura plc Tel: 01925 945354
David Purcell, Investor Relations Director Email: Investor@assura.co.uk
FGS Global Tel: 0207 251 3801
Gordon Simpson Email: Assura@fgsglobal.com
James Thompson
Notes to Editors
Assura plc is a national healthcare premises specialist and UK REIT based in
Altrincham, UK - caring for more than 600 primary healthcare buildings, from
which over six million patients are served.
A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023,
Assura's portfolio was valued at £2.7 billion.
At Assura, we BUILD for health. Assura builds better spaces for people and
places, invests in skills and inspires new ways of working, and unlocks the
power of design and innovation to deliver lasting impact for communities -
aiming for six million people to have benefitted from improvements to and
through its healthcare buildings by 2026.
Assura is leading for a sustainable future, targeting net zero carbon across
its portfolio by 2040.
Further information is available at www.assuraplc.com
(http://www.assuraplc.com)
*EPRA is a registered trademark of the European Public Real Estate Association
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END CRODZGFVVGLGFZM